The expression of sEV markers CD63, CD81 and Alix were considerably enhanced in HE-treated SiHa and Hela cells, and the negative control marker, Calnexin, showed deletion of expression, which verified the identity of sEVs (Additional file 1: Fig. S1D, E). The gene discussed is CD63; the disease is hereditary elliptocytosis.